DY
Dyne Therapeutics, Inc.
DYN · NASDAQ
$17.12 -0.98% (-$0.17)
1M -34.13%
Market Cap $3.20B
P/E Ratio -
Div. Yield -
ROE 64.30%
Bulios Fair Price
$10.38
39.4% downside
Trenutna cena
$17.12
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DYN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
43 /100
Fair P/B 4.55x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 56.76%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 52.25%
ROIC 58.28%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -33.40x
Debt/Equity 0.03x
Current ratio 12.02x
Stability
68 /100
Stable Profitable years 0
Beta 1.08x
EPS volatility 18.49%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DYN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John G. Cox
Employees
289
Headquarters
Waltham
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report